Metropolitan Life Insurance CO Enanta Pharmaceuticals Inc Transaction History

Metropolitan Life Insurance CO

$252 Million
Q4 2024

39 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$38.82 - $54.59 $6,172 - $8,679	-159 Reduced 12.49%	1,114 $45,000
Q4 2022 Jun 14, 2023	BUY	$40.77 - $53.73 $6,482 - $8,543	159 Added 14.27%	1,273 $59.2 Million
Q3 2022 Jun 14, 2023	BUY	$48.29 - $71.27 $7,678 - $11,331	159 Added 14.27%	1,273 $66 Million
Q2 2022 Jun 20, 2023	BUY	$38.13 - $76.93 $6,062 - $12,231	159 Added 14.27%	1,273 $60,000
Q1 2022 Jun 20, 2023	BUY	$56.06 - $74.11 $8,913 - $11,783	159 Added 14.27%	1,273 $90,000
Q1 2022 Mar 30, 2023	SELL	$56.06 - $74.11 $232,032 - $306,741	-4,139 Reduced 76.48%	1,273 $90,000
Q1 2022 May 12, 2022	SELL	$56.06 - $74.11 $232,032 - $306,741	-4,139 Reduced 76.48%	1,273 $91,000
Q4 2021 Jun 21, 2023	BUY	$60.19 - $97.37 $258,696 - $418,496	4,298 Added 385.82%	5,412 $404,000
Q3 2021 Jun 21, 2023	BUY	$41.02 - $58.65 $176,303 - $252,077	4,298 Added 385.82%	5,412 $307,000
Q3 2021 Mar 30, 2023	BUY	$41.02 - $58.65 $4,102 - $5,865	100 Added 1.88%	5,412 $307,000
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $4,102 - $5,865	100 Added 1.88%	5,412 $307,000
Q2 2021 Jun 21, 2023	BUY	$43.76 - $53.11 $183,704 - $222,955	4,198 Added 376.84%	5,312 $233,000
Q2 2021 Mar 30, 2023	SELL	$43.76 - $53.11 $43 - $53	-1 Reduced 0.02%	5,312 $233,000
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $232,234 - $281,854	5,307 Added 106140.0%	5,312 $234,000
Q1 2021 Jun 26, 2023	BUY	$41.69 - $54.95 $175,056 - $230,735	4,199 Added 376.93%	5,313 $262 Million
Q1 2021 May 14, 2021	SELL	$41.69 - $54.95 $221,290 - $291,674	-5,308 Reduced 99.91%	5 $262,000
Q4 2020 Jun 22, 2023	BUY	$41.16 - $47.47 $172,830 - $199,326	4,199 Added 376.93%	5,313 $223,000
Q3 2020 Jun 26, 2023	BUY	$43.36 - $53.53 $182,068 - $224,772	4,199 Added 376.93%	5,313 $243,000
Q3 2020 Mar 30, 2023	SELL	$43.36 - $53.53 $54,720 - $67,554	-1,262 Reduced 19.19%	5,313 $243,000
Q3 2020 Nov 13, 2020	SELL	$43.36 - $53.53 $54,720 - $67,554	-1,262 Reduced 19.19%	5,313 $243,000
Q2 2020 Jun 26, 2023	BUY	$46.37 - $57.58 $253,226 - $314,444	5,461 Added 490.22%	6,575 $330,000
Q2 2020 Mar 30, 2023	BUY	$46.37 - $57.58 $51,053 - $63,395	1,101 Added 20.11%	6,575 $330,000
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $51,053 - $63,395	1,101 Added 20.11%	6,575 $330,000
Q1 2020 Jul 12, 2023	BUY	$40.22 - $62.0 $183,724 - $283,216	4,568 Added 410.05%	5,682 $292,000
Q4 2019 Jul 12, 2023	BUY	$57.95 - $66.61 $252,662 - $290,419	4,360 Added 391.38%	5,474 $338,000
Q3 2019 Jul 12, 2023	BUY	$60.08 - $88.17 $261,948 - $384,421	4,360 Added 391.38%	5,474 $328,000
Q2 2019 Jul 12, 2023	BUY	$81.3 - $97.35 $354,468 - $424,446	4,360 Added 391.38%	5,474 $461,000
Q1 2019 Jul 13, 2023	BUY	$69.08 - $105.66 $301,188 - $460,677	4,360 Added 391.38%	5,474 $522,000
Q1 2019 Mar 30, 2023	BUY	$69.08 - $105.66 $290,205 - $443,877	4,201 Added 330.01%	5,474 $522,000
Q1 2019 May 16, 2019	SELL	$69.08 - $105.66 $4.48 Million - $6.85 Million	-64,802 Reduced 92.21%	5,474 $522,000
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $4.48 Million - $6.85 Million	64,802 Added 1183.81%	70,276 $1.42 Million
Q4 2018 Jul 13, 2023	BUY	$65.41 - $84.65 $285,187 - $369,074	4,360 Added 391.38%	5,474 $387,000
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $279,627 - $361,878	4,275 Added 356.55%	5,474 $388,000
Q3 2018 Jul 13, 2023	BUY	$85.46 - $126.37 $372,605 - $550,973	4,360 Added 391.38%	5,474 $468 Million
Q3 2018 Nov 14, 2018	SELL	$85.46 - $126.37 $365,341 - $540,231	-4,275 Reduced 78.1%	1,199 $102,000
Q2 2018 Aug 15, 2018	BUY	$81.85 - $120.51 $38,633 - $56,880	472 Added 9.44%	5,474 $0
Q4 2017 Feb 15, 2018	SELL	$45.65 - $59.37 $257,466 - $334,846	-5,640 Reduced 53.0%	5,002 $294,000
Q3 2017 Nov 14, 2017	SELL	$37.91 - $46.8 $38,592 - $47,642	-1,018 Reduced 8.73%	10,642 $498,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,660	11,660 $420,000

Others Institutions Holding ENTA

# of Institutions

107

Shares Held

18.3M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$15.1 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$14.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$13.2 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$10.7 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.22M
Shares

$8.72 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $148M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account